{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:53:25Z","timestamp":1740128005816,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI127807","GM041916","T32 AI070117"],"award-info":[{"award-number":["AI127807","GM041916","T32 AI070117"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jbc.2021.100342","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T11:34:51Z","timestamp":1612006491000},"page":"100342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A resistant mutant of Plasmodium falciparum purine nucleoside phosphorylase uses wild-type neighbors to maintain parasite survival"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8834-0119","authenticated-orcid":false,"given":"Yacoba V.T.","family":"Minnow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh K.","family":"Harijan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8056-1929","authenticated-orcid":false,"given":"Vern L.","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2019","series-title":"World Malaria Report","key":"10.1016\/j.jbc.2021.100342_bib1"},{"key":"10.1016\/j.jbc.2021.100342_bib2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm.4381","article-title":"Antimalarial drug resistance: Linking Plasmodium falciparum parasite biology to the clinic","volume":"23","author":"Blasco","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2021.100342_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/cc2183","article-title":"Clinical review: Severe malaria","volume":"7","author":"Trampuz","year":"2003","journal-title":"Crit. Care"},{"key":"10.1016\/j.jbc.2021.100342_bib4","first-page":"2630825","article-title":"Severe case of Plasmodium falciparum malaria in a pregnant woman from Nigeria","volume":"2019","author":"Yagnik","year":"2019","journal-title":"Case Rep. Infect. Dis."},{"key":"10.1016\/j.jbc.2021.100342_bib5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.pt.2016.05.010","article-title":"Artemisinin action and resistance in Plasmodium falciparum","volume":"32","author":"Tilley","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.jbc.2021.100342_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","article-title":"The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: A molecular epidemiology observational study","volume":"17","author":"Imwong","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jbc.2021.100342_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau3174","article-title":"Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay","volume":"11","author":"Dziekan","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2021.100342_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4269\/ajtmh.15-0477","article-title":"A\u00a0unique Plasmodium falciparum K13 gene mutation in Northwest Ethiopia","volume":"94","author":"Bayih","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jbc.2021.100342_bib9","doi-asserted-by":"crossref","first-page":"35899","DOI":"10.1074\/jbc.M807218200","article-title":"Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites","volume":"283","author":"Madrid","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100342_bib10","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1074\/jbc.M105906200","article-title":"Purine-less death in Plasmodium falciparum induced by immucillin-H, a transition state analogue of purine nucleoside phosphorylase","volume":"277","author":"Kicska","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100342_bib11","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4155\/fmc.13.51","article-title":"Transition-state inhibitors of purine salvage and other prospective enzyme targets in malaria","volume":"5","author":"Ducati","year":"2013","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jbc.2021.100342_bib12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nbt0905-1089","article-title":"Protozoan genomics for drug discovery","volume":"23","author":"Chaudhary","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbc.2021.100342_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026916","article-title":"Plasmodium falciparum parasites are killed by a transition state analogue of purine nucleoside phosphorylase in a primate animal model","volume":"6","author":"Cassera","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.100342_bib14","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.2174\/156802611796575948","article-title":"Purine and pyrimidine pathways as targets in Plasmodium falciparum","volume":"11","author":"Cassera","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jbc.2021.100342_bib15","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1021\/bi0359123","article-title":"Transition state analysis for human and Plasmodium falciparum purine nucleoside phosphorylases","volume":"43","author":"Lewandowicz","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.100342_bib16","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/EC.00159-08","article-title":"Purine salvage pathways in the intraerythrocytic malaria parasite Plasmodium falciparum","volume":"7","author":"Downie","year":"2008","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.jbc.2021.100342_bib17","doi-asserted-by":"crossref","first-page":"18103","DOI":"10.1074\/jbc.C400068200","article-title":"Plasmodium falciparum purine nucleoside phosphorylase: Crystal structures, immucillin inhibitors, and dual catalytic function","volume":"279","author":"Shi","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100342_bib18","doi-asserted-by":"crossref","first-page":"25652","DOI":"10.1074\/jbc.M602624200","article-title":"Toxoplasma gondii purine nucleoside phosphorylase biochemical characterization, inhibitor profiles, and comparison with the Plasmodium falciparum ortholog","volume":"281","author":"Chaudhary","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100342_bib19","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1073\/pnas.1525670115","article-title":"Genetic resistance to purine nucleoside phosphorylase inhibition in Plasmodium falciparum","volume":"115","author":"Ducati","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.100342_bib20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nature14412","article-title":"A\u00a0molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria","volume":"520","author":"Mbengue","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.100342_bib21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm.3073","article-title":"Malaria biology and disease pathogenesis: Insights for new treatments","volume":"19","author":"Miller","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2021.100342_bib22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2021.100342_bib23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrd1416","article-title":"Antimalarial drug discovery: Efficacy models for compound screening","volume":"3","author":"Fidock","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2021.100342_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1126\/science.aan4472","article-title":"Mapping the malaria parasite druggable genome by using in\u00a0vitro evolution and chemogenomics","volume":"359","author":"Cowell","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jbc.2021.100342_bib25","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1128\/AAC.00241-08","article-title":"Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness","volume":"53","author":"Preechapornkul","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jbc.2021.100342_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3347\/kjp.2019.57.4.369","article-title":"Molecular surveillance of Pfkelch13 and Pfmdr1 mutations in Plasmodium falciparum isolates from southern Thailand","volume":"57","author":"Khammanee","year":"2019","journal-title":"Korean J. Parasitol."},{"key":"10.1016\/j.jbc.2021.100342_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2875-8-11","article-title":"Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia","volume":"8","author":"Lim","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.jbc.2021.100342_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","article-title":"Drug resistance in Plasmodium","volume":"16","author":"Haldar","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jbc.2021.100342_bib29","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1509150","article-title":"Dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy","volume":"374","author":"Kakuru","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2021.100342_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4269\/ajtmh.2012.11-0410","article-title":"Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria","volume":"87","author":"Adam","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jbc.2021.100342_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002606","article-title":"Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial","volume":"15","author":"Jagannathan","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.jbc.2021.100342_bib32","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","article-title":"Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: A multicentre, open-label, randomised clinical trial","volume":"395","author":"van der Pluijm","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2021.100342_bib33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/9367","article-title":"Transition-state analogs as inhibitors of human and malarial hypoxanthine-guanine phosphoribosyltransferases","volume":"6","author":"Li","year":"1999","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.jbc.2021.100342_bib34","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1021\/acs.accounts.5b00002","article-title":"Transition states and transition state analogue interactions with enzymes","volume":"48","author":"Schramm","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jbc.2021.100342_bib35","first-page":"201","article-title":"The behavior and significance of slow-binding enzyme inhibitors","volume":"61","author":"Morrison","year":"1988","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"10.1016\/j.jbc.2021.100342_bib36","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2021.100342_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1021\/cb300631k","article-title":"Transition states, analogues, and drug development","volume":"8","author":"Schramm","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2021.100342_bib38","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1021\/bi401589n","article-title":"Catalytic site cooperativity in dimeric methylthioadenosine nucleosidase","volume":"53","author":"Wang","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2021.100342_bib39","doi-asserted-by":"crossref","first-page":"11194","DOI":"10.1021\/acs.chemrev.8b00369","article-title":"Enzymatic transition states and drug design","volume":"118","author":"Schramm","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jbc.2021.100342_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007722","article-title":"Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in\u00a0vitro and synergize with multiple antimalarial agents","volume":"15","author":"Stokes","year":"2019","journal-title":"PLoS Pathog."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821001149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821001149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T03:38:05Z","timestamp":1634441885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925821001149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":40,"alternative-id":["S0021925821001149"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2021.100342","relation":{},"ISSN":["0021-9258"],"issn-type":[{"type":"print","value":"0021-9258"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A resistant mutant of Plasmodium falciparum purine nucleoside phosphorylase uses wild-type neighbors to maintain parasite survival","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2021.100342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2021.100526","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100342"}}